Drug Shortage Report for BIO-ROSUVASTATIN
Report ID | 71985 |
Drug Identification Number | 02444984 |
Brand name | BIO-ROSUVASTATIN |
Common or Proper name | ROSUVASTATIN |
Company Name | BIOMED PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | ROSUVASTATIN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-01-11 |
Estimated end date | |
Actual end date | 2019-09-20 |
Shortage status | Resolved |
Updated date | 2019-09-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2019-09-25 | French | Compare |
v8 | 2019-09-25 | English | Compare |
v7 | 2019-05-15 | French | Compare |
v6 | 2019-05-15 | English | Compare |
v5 | 2019-03-21 | French | Compare |
v4 | 2019-03-21 | English | Compare |
v3 | 2019-01-12 | English | Compare |
v2 | 2019-01-11 | French | Compare |
v1 | 2019-01-11 | English | Compare |
Showing 1 to 9 of 9